See the DrugPatentWatch profile for iqirvo
When was the patent for Iqirvo filed, and when did it expire?
“Iqirvo” is elafibranor. The exact filing and expiration dates depend on the specific patent(s) covering elafibranor, because a drug’s IP portfolio usually includes multiple patent families and later-filed improvements.
I don’t have the provided source details needed to state the filing date or the expiration date for the Iqirvo patent(s) accurately.
If you share the patent number (or a link to the patent record you mean), I can tell you the filing date and the projected expiration from that record.
Which patent do people usually mean for Iqirvo?
Most searches for “Iqirvo patent” refer to one of these:
- The original composition-of-matter patent covering the drug substance.
- A method-of-use patent (how it’s used for a specific indication).
- Patents on formulations, intermediates, or process improvements.
Different patents will have different timelines, so the answer changes depending on which one you mean.
Quick way to get the right answer
If you paste any of the following, I can give the precise dates:
- Patent number(s) (e.g., “US…”, “EP…”, “WO…”)
- Jurisdiction (US/EP/UK/etc.)
- The patent link you’re looking at (Espacenet, Google Patents, FDA Orange Book, etc.)
Sources
I’m missing the underlying patent information needed to cite dates for Iqirvo’s patent(s).